MOTILITY AND VISCERAL SENSATION

Effects of glucagon-like peptide-1(7–36)amide on motility and sensation of the proximal stomach in humans

J Schirra¹, U Wank¹, R Arnold¹, B Göke², M Katschinski¹

¹ Department of Gastroenterology and Endocrinology, Philipps-University, Marburg, Germany
² Department of Gastroenterology, Ludwig-Maximilians University, Munich, Germany

Correspondence to:
Correspondence to:
Professor M Katschinski, Department of Gastroenterology, Baldingerstr, 35033 Marburg, Germany;
katschin{at}post.med.uni-marburg.de

Background: Glucagon-like peptide-1(7–36)amide (GLP-1) retards gastric emptying, reduces food intake, and inhibits antroduodenal and stimulates pyloric motility.

Aims: To assess the effects of synthetic GLP-1 on fundus tone and volume waves, gastric compliance, and perception of gastric distension.

Subjects: Eleven healthy male volunteers.

Methods: Background infusions were saline, or GLP-1 at 0.3 or 0.9 pmol/ kg/min on separate days in random order. Interdigestive fundus motility was recorded by barostat (maximum capacity of intragastric bag 1200 ml) during basal and peptide periods of 60 minutes each. Thereafter stepwise isobaric distensions were performed with ongoing peptide infusion, and gastric sensation was scored.

Results: Low and high loads of GLP-1 induced physiological and supraphysiological plasma immunoreactivities, respectively. GLP-1 dose dependently diminished fundus tone (162.9 (15.0) and 259.5 (17.2) v 121.1 (6.0) ml with saline; p<0.0001). It greatly reduced volume waves and total volume displaced by these events (p<0.0001). Gastric compliance derived from isobaric distension rose in a dose related manner (42.6 (5.5) and 63.6 (7.7) v 27.0 (3.5) ml/mm Hg; p=0.0004) with a concomitant reduction of the pressure at half maximum bag volume (6.4 (0.4) and 5.5 (0.4) v 7.2 (0.1) mm Hg; p<0.0001). GLP-1 did not change perception of isobaric distension but reduced the perception score related to corresponding bag volume (p<0.0001).

Conclusions: GLP-1 is a candidate physiological inhibitory regulator of fundus motility. It allows the stomach to afford a larger volume without increase in sensation.

Keywords: barostat; gastric compliance; gastric tone; isobaric distension; volume waves

Abbreviations: CCK, cholecystokinin; GLP-1, glucagon-like peptide-1(7-36)amide; IR, immunoreactive; MDP, minimal distending pressure; PP, pancreatic polypeptide

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Young, R L, Sutherland, K, Pezos, N, Brierley, S M, Horowitz, M, Rayner, C K, Blackshaw, L A (2009). Expression of taste molecules in the upper gastrointestinal tract in humans with and without type 2 diabetes. Gut 58: 337-346 [Abstract] [Full Text]  
• Dalla Man, C., Bock, G., Giesler, P. D., Serra, D. B., Ligueros Saylan, M., Foley, J. E., Camilleri, M., Toffolo, G., Cobelli, C., Rizza, R. A., Vella, A. (2009). Dipeptidyl Peptidase-4 Inhibition by Vildagliptin and the Effect on Insulin Secretion and Action in Response to Meal Ingestion in Type 2 Diabetes. Diabetes Care 32: 14-18 [Abstract] [Full Text]  
• Vella, A., Bock, G., Giesler, P. D., Burton, D. B., Serra, D. B., Saylan, M. L., Dunning, B. E., Foley, J. E., Rizza, R. A., Camilleri, M. (2007). Effects of Dipeptidyl Peptidase-4 Inhibition on Gastrointestinal Function, Meal Appearance, and Glucose Metabolism in Type 2 Diabetes. Diabetes 56: 1475-1480 [Abstract] [Full Text]  
• Raun, K., von Voss, P., Gotfredsen, C. F., Golozoubova, V., Rolin, B., Knudsen, L. B. (2007). Liraglutide, a Long-Acting Glucagon-Like Peptide-1 Analog, Reduces Body Weight and Food Intake in Obese Candy-Fed Rats, Whereas a Dipeptidyl Peptidase-IV Inhibitor, Vildagliptin, Does Not. Diabetes 56: 8-15 [Abstract] [Full Text]  
• Little, T. J., Pilichiewicz, A. N., Russo, A., Phillips, L., Jones, K. L., Nauck, M. A., Wishart, J., Horowitz, M., Feinle-Bisset, C. (2006). Effects of Intravenous Glucagon-Like Peptide-1 on Gastric Emptying and Intragastric Distribution in Healthy Subjects: Relationships with Postprandial Glycemic and Insulinemic Responses. J. Clin. Endocrinol. Metab. 91: 1916-1923 [Abstract] [Full Text]  
• Schirra, J, Nicolaus, M, Roggel, R, Katschinski, M, Storr, M, Woerle, H J, Goke, B (2006). Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans. Gut 55: 243-251 [Abstract] [Full Text]  
• Chelikani, P. K., Haver, A. C., Reidelberger, R. D. (2005). Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288: R1695-R1706 [Abstract] [Full Text]  
• D'Alessio, D. A., Vahl, T. P. (2004). Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes. Am. J. Physiol. Endocrinol. Metab. 286: E882-E890 [Abstract] [Full Text]  
• van den Elzen, B D J, Bennink, R J, Wieringa, R E, Tytgat, G N J, Boeckxstaens, G E E (2003). Fundic accommodation assessed by SPECT scanning: comparison with the gastric barostat. Gut 52: 1548-1554 [Abstract] [Full Text]  
• DeMeo, M. T., Bruninga, K. (2002). Physiology of the Aerodigestive System and Aberrations in That System Resulting in Aspiration. JPEN J Parenter Enteral Nutr 26: S9-S18 [Abstract]